HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong · Delayed Price · Currency is HKD 2.600
+0.020 (0.78%)
Feb 13, 2026, 4:08 PM HKT
HighTide Therapeutics Market Cap
HighTide Therapeutics has a market cap or net worth of 1.49 billion as of February 13, 2026. Its market cap has increased by 142.49% in one year.
Market Cap
1.49B
Enterprise Value
1.16B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.60
Market Cap Chart
Since December 22, 2023, HighTide Therapeutics's market cap has decreased from 6.37B to 1.49B, a decrease of -76.69%. That is a compound annual growth rate of -49.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.47B | -12.54% |
| Dec 31, 2025 | 1.69B | 157.80% |
| Dec 31, 2024 | 653.76M | -90.20% |
| Dec 29, 2023 | 6.67B | 4.68% |
| Dec 22, 2023 | 6.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mabpharm | 2.06B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 2.01B |
| Zhaoke Ophthalmology | 1.91B |
| Cutia Therapeutics | 1.86B |
| CANbridge Pharmaceuticals | 1.61B |
| Immunotech Biopharm | 1.56B |
| Shanghai Bio-heart Biological Technology | 1.46B |
| Wuhan YZY Biopharma | 1.40B |